Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02674750
Title Study to Evaluate the Efficacy and Safety of CUDC-907 in Patients With RR DLBCL, Including Patients With MYC Alterations
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Curis, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ESP


No variant requirements are available.